|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HEALTH POLICY AND ETHICS |
Roberto Rivera and David Borasky are with the Office of International Research Ethics, Family Health International, Research Triangle Park, NC. Robert Rice and Florence Carayon are with Field, Information, and Training Services, Family Health International, Research Triangle Park. Emelita Wong is with Family Health International, Research Triangle Park.
Correspondence: Requests for reprints should be sent to Roberto Rivera, MD, Office of International Research Ethics, Family Health International, P.O. Box 13950, Research Triangle Park, NC 27713 (e-mail: rrivera{at}fhi.org).
We reported 164 researchers recommendations for information that should be included in the informed consent process. These recommendations were obtained during training workshops conducted in Africa, Europe, and the United States.
The 8 elements of informed consent of the US Code of Federal Regulations were used to identify 95 items of information ("points"), most related to benefits and research description. Limited consensus was found among the 3 workshops: of the 95 points, only 27 (28%) were identified as useful by all groups.
These points serve as a springboard for identifying information applicable in different geographic areas and indicate the need for involving a variety of individuals and stakeholders, with different research and cultural perspectives, in the development of informed consent, particularly for research undertaken in international settings.
This article has been cited by other articles:
![]() |
I S Durand-Zaleski, C Alberti, P Durieux, X Duval, S Gottot, P. Ravaud, S Gainotti, C Vincent-Genod, D Moreau, and P Amiel Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception J. Med. Ethics, September 1, 2008; 34(9): e16 - e16. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |